{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T15:39:42Z","timestamp":1779896382860,"version":"3.53.1"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>To evaluate severe maternal morbidity (SMM) among patients with epilepsy and patients without epilepsy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS:<\/jats:title>\n            <jats:p>We retrospectively examined SMM using linked birth certificate and maternal hospital discharge records in California between 2007 and 2012. Epilepsy present at delivery admission was the exposure and was subtyped into generalized, focal and other less specified, or unspecified. The outcomes were SMM and nontransfusion SMM from delivery up to 42 days\u2019 postpartum, identified using Centers for Disease Control and Prevention indicators. Multivariable logistic regression models were used to adjust for confounders, which were selected a priori. We also estimated the association between epilepsy and SMM independent of comorbidities by using a validated obstetric comorbidity score. Severe maternal morbidity indicators were then compared using the same multivariable logistic regression models.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>Of 2,668,442 births, 8,145 (0.3%) were to patients with epilepsy; 637 (7.8%) had generalized, 6,250 (76.7%) had focal or other less specified, and 1,258 (15.4%) had unspecified subtypes. Compared with patients without epilepsy, patients with epilepsy had greater odds of SMM (4.3% vs 1.4%, adjusted odds ratio [aOR] 2.91, 95% CI 2.61\u20133.24) and nontransfusion SMM (2.9% vs 0.7%, aOR 4.16, 95% CI 3.65\u20134.75). Epilepsy remained significantly associated with increased SMM and nontransfusion SMM after additional adjustment for the obstetric comorbidity score, though the effects were attenuated. When grouped by organ system, all SMM indicators were significantly more common among patients with epilepsy\u2014most notably those related to hemorrhage and transfusion.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION:<\/jats:title>\n            <jats:p>Severe maternal morbidity was significantly increased in patients with epilepsy, and SMM indicators across all organ systems contributed to this.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aog.0000000000004562","type":"journal-article","created":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T05:01:10Z","timestamp":1633669270000},"page":"747-754","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":18,"title":["Association of Epilepsy and Severe Maternal Morbidity"],"prefix":"10.1097","volume":"138","author":[{"given":"Danielle M.","family":"Panelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie A.","family":"Leonard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyi","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimford J.","family":"Meador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"McElrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly F.","family":"Darmawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzan L.","family":"Carmichael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deirdre J.","family":"Lyell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser Y.","family":"El-Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice L.","family":"Druzin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany C.","family":"Herrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,10,6]]},"reference":[{"key":"R1-20250423","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.0013-9580.2004.06204.x","article-title":"Practice parameters, efficacy, and tolerability of the new antiepileptic drugs: treatment of new-onset epilepsy. Report of the TTA and QSS subcommittees of the American Academy of Neurology and the American Epilepsy Society","volume":"45","author":"French","year":"2004","journal-title":"Epilepsia"},{"key":"R3-20250423","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/AOG.0000000000004211","article-title":"Seizures: clinical updates in women's health care primary and preventive care review","volume":"137","author":"Hessler","year":"2021","journal-title":"Obstet Gynecol"},{"key":"R4-20250423","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1001\/jamaneurol.2015.1017","article-title":"Mortality and morbidity during delivery hospitalization among pregnant women with epilepsy in the United States","volume":"72","author":"MacDonald","year":"2015","journal-title":"JAMA Neurol"},{"key":"R5-20250423","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.seizure.2017.05.004","article-title":"Epilepsy and pregnancy: for healthy pregnancies and happy outcomes. Suggestions for service improvements from the Multispecialty UK Epilepsy Mortality Group","volume":"50","author":"Leach","year":"2017","journal-title":"Seizure"},{"key":"R6-20250423","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/S0140-6736(15)00045-8","article-title":"Epilepsy in pregnancy and reproductive outcomes: a systematic review and meta-analysis","volume":"386","author":"Viale","year":"2015","journal-title":"Lancet"},{"key":"R7-20250423","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S1474-4422(18)30495-2","article-title":"Management of epilepsy in women","volume":"18","author":"Stephen","year":"2019","journal-title":"Lancet Neurol"},{"key":"R8-20250423","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/epi.12621","article-title":"SUDEP and epilepsy-related mortality in pregnancy","volume":"55","author":"Edey","year":"2014","journal-title":"Epilepsia"},{"key":"R9-20250423","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1212\/WNL.0b013e3181a6b2f8","article-title":"Practice parameter update: management issues for women with epilepsy\u2014focus on pregnancy (an evidence-based review): obstetrical complications and change in seizure frequency: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society","volume":"73","author":"Harden","year":"2009","journal-title":"Neurology"},{"key":"R10-20250423","doi-asserted-by":"crossref","first-page":"643.e1","DOI":"10.1016\/j.ajog.2015.11.004","article-title":"Measuring severe maternal morbidity: validation of potential measures","volume":"214","author":"Main","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"R11-20250423","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/GRF.0000000000000361","article-title":"Reducing maternal mortality and severe maternal morbidity through state-based quality improvement initiatives","volume":"61","author":"Main","year":"2018","journal-title":"Clin Obstet Gynecol"},{"key":"R13-20250423","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/AOG.0000000000004022","article-title":"An expanded obstetric comorbidity scoring system for predicting severe maternal morbidity","volume":"136","author":"Leonard","year":"2020","journal-title":"Obstet Gynecol"},{"key":"R14-20250423","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1001\/jamaneurol.2017.1310","article-title":"Association between pregnancy and perinatal outcomes among women with epilepsy","volume":"74","author":"Razaz","year":"2017","journal-title":"JAMA Neurol"},{"key":"R15-20250423","first-page":"869","article-title":"The validity of information on \u201crace\u201d and \u201cHispanic ethnicity\u201d in California birth certificate data","volume":"35","author":"Baumeister","year":"2000","journal-title":"Health Serv Res"},{"key":"R16-20250423","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/AOG.0b013e3182a603bb","article-title":"Development of a comorbidity index for use in obstetric patients","volume":"122","author":"Bateman","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R17-20250423","doi-asserted-by":"crossref","first-page":"271.e1","DOI":"10.1016\/j.ajog.2019.06.025","article-title":"A comorbidity-based screening tool to predict severe maternal morbidity at the time of delivery","volume":"221","author":"Easter","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"R18-20250423","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v042.i08","article-title":"MatchIt: nonparametric preprocessing for","volume":"42","author":"Ho","year":"2011","journal-title":"J Stat Softw"},{"key":"R19-20250423","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1471-0528.2011.03004.x","article-title":"Obstetric outcome in women with epilepsy: a hospital-based, retrospective study","volume":"118","author":"Borthen","year":"2011","journal-title":"BJOG"},{"key":"R20-20250423","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00381-019-04435-2","article-title":"The impact of maternal epilepsy on delivery and neonatal outcomes","volume":"36","author":"Melikova","year":"2020","journal-title":"Child\u2019s Nerv Syst"},{"key":"R21-20250423","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.3310\/hta11370","article-title":"A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial","volume":"11","author":"Marson","year":"2007","journal-title":"Health Technol Assess"},{"key":"R22-20250423","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/2042098611411127","article-title":"New generation antiepileptic drugs: what do they offer in terms of improved tolerability and safety?","volume":"2","author":"French","year":"2011","journal-title":"Ther Adv Drug Saf"},{"key":"R23-20250423","first-page":"1","article-title":"Antiepileptic drug treatment patterns in women of childbearing age with epilepsy","volume":"94304","author":"Kim","year":"2019","journal-title":"JAMA Neurol"},{"key":"R24-20250423","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.yebeh.2018.04.009","article-title":"Changes in antiepileptic drug-prescribing patterns in pregnant women with epilepsy","volume":"84","author":"Meador","year":"2018","journal-title":"Epilepsy Behav"},{"key":"R25-20250423","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-017-0845-1","article-title":"Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes","volume":"15","author":"Veroniki","year":"2017","journal-title":"BMC Med"},{"key":"R26-20250423","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1212\/WNL.0000000000002119","article-title":"Developmental effects of antiepileptic drugs and the need for improved regulations","volume":"86","author":"Meador","year":"2016","journal-title":"Neurology"},{"key":"R27-20250423","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1600-0404.2009.01260.x","article-title":"Changing patterns of antiepileptic drug use in pregnant Australian women","volume":"121","author":"Vajda","year":"2010","journal-title":"Acta Neurol Scand"},{"key":"R28-20250423","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/ane.12816","article-title":"Anti-epileptic drug exposure and risk of foetal death in utero","volume":"137","author":"Vajda","year":"2017","journal-title":"Acta Neurol Scand"},{"key":"R29-20250423","first-page":"1","article-title":"Births: final data for 2019","volume":"70","author":"Martin","year":"2021","journal-title":"Natl Vital Stat Rep"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000004562","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T18:03:09Z","timestamp":1745431389000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000004562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,6]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000004562","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,6]]},"assertion":[{"value":"2021-05-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}